The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India
Open accessAbstract
Background: Despite the high incidence of cervical cancer reported from India, large scale population based studies on the HPV prevalence and genotype distribution are very few from this region. In view of the clinical trials for HPV vaccine taking place in India, it is of utmost importance to understand the prevalence of HPV genotypes in various geographical regions of India. We investigated the genotype distribution of high-risk HPV types in squamous cell carcinomas and the prevalence of high-risk HPV in cervicovaginal samples in the southern state of Andhra Pradesh (AP), India. Methods: HPV genotyping was done in cervical cancer specimens (n = 41) obtained from women attending a regional cancer hospital in Hyderabad. HPV-DNA testing was also done in cervicovaginal samples (n = 185) collected from women enrolled in the cervical cancer screening pilot study conducted in the rural community, of Medchal Mandal, twenty kilometers away from Hyderabad. Results: High-risk HPV types were found in 87.8% (n = 36/41) of the squamous cell carcinomas using a PCR-based line blot assay. Among the HPV positive cancers, the overall type distribution of the major high-risk HPV types was as follows: HPV 16 (66.7%), HPV 18 (19.4%), HPV 33 (5.6%), HPV 35 (5.6%), HPV 45 (5.6%), HPV 52 (2.8%), HPV 58(2.8%), HPV 59(2.8%) and HPV 73 (2.8%). Women participating in the community screening programme provided both a self-collected vaginal swab and a clinician-collected cervical swab for HPV DNA testing. Primary screening for high risk HPV was performed using the Digene Hybrid Capture 2 (hc2) assay. All hc2 positive samples by any one method of collection were further analyzed using the Roche PCR-based line blot for genotype determination. The prevalence of high risk HPV infection in this community-based screening population was 10.3% (19/185) using the clinician-collected and 7.0% (13/185) using the self-collected samples. The overall agreement between self-collected and clinician-collected samples was 92%; however among HPV-positive specimens, the HPV agreement was only moderate (39.1%). The most frequently detected HPV types in the Medchal community are HPV 52 and 16. Conclusion: Our results suggest that the HPV type distribution in both cervical cancer tissues and in a general screening population from Andhra Pradesh is similar to that reported in India and other parts of the world. We also conclude that an effective vaccine targeting HPV 16 will reduce the cervical cancer burden in AP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Data on the prevalence and distribution of three most prominent genotypes in the cancer cases from different geographical regions of India shows a great regional variation [5–9, 15–17].”
From HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India (2017) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As compared to other studies, the overall prevalence of HPV 16 and 18 in cancer cases (82.3%) is much higher in the present work [7, 8, 16].”
From HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India (2017) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to other studies in India, the present study disclosed a high prevalence of HPV infection among the women with normal cytology showing minor gynecological complaint [5, 6, 15–17].”
From HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India (2017) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Sample size: Assuming HPV prevalence among the women to be 7%–10% based on the published reports, 19 , 20 and concordance rate of 80%, at 95% confidence interval (CI) and power of 80%, between samples collected by HCW and self‐collected samples, around 1600 women were needed to undergo HPV testing by both the methods.”
From Acceptability and validity of HPV self‐sampling for cervical cancer screening among women living in different ecological settings in India (2025) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Reports from south India showed HPV 16 and HPV18 accounts for 58–69% and 5–19.4% of ICC cases respectively [16, 18].”
From HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India (2017) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“The most prevalent genotype in cervical cancer was HPV 16 followed by18 is in accordance with international and local data [7, 8, 16].”
From HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India (2017) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“Analysis of genotypes distribution in ICC cases showed that HPV 16(83.78%) and 18(21.08%) were the most predominant genotypes which is quite similar to the studies reported from India and worldwide.”
From HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India (2017) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Self-citationPrevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M. E., Jansen, A. M., Peto, J., SCHIFFMAN, M. H., Moreno, V. R., Kurman, R. J., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,339
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,719
Harper, D. M., Franco, E. L., Wheeler, C. M., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B. L., Naud, P., de Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,639
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñóz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,562
Improved Amplification of Genital Human Papillomaviruses
Gravitt, P. E., Peyton, C. L., Alessi, T. Q., Wheeler, C. M., Coutlée, F., Hildesheim, A., Schiffman, M. H., Scott, D. R., & Apple, R. J. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.357-361.2000 · Cited by 1,137
Self-citationMuñóz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjosé, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,095
Self-citation(1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.1.1 · Cited by 688
Gravitt, P. E., Peyton, C. L., Apple, R. J., & Wheeler, C. M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.3020-3027.1998 · Cited by 635
Self-citationHuman papillomavirus and cancer: the epidemiological evidence
Muñóz, N. (2000) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00125-6 · Cited by 576
Research works printed but not linked: 1
- Preparation and ananlysis of DNA. Short protocols in molecular biology. Edited by: Ausubel et al. 1995, New York: Wiley, 3
Cited by
Sorted by citations
Epidemiology of cervical cancer with special focus on India
Aswathy, S., Reshma, J., & Dinesh, A. (2015) · International Journal of Women s Health · doi:10.2147/ijwh.s50001 · Cited by 262
Human papillomavirus type distribution in women from Asia: a meta-analysis
Bao, Y., Li, N., Smith, J. S., Qiao, Y., & members, A. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.00959.x · Cited by 213
Rashid, S., Labani, S., & Das, B. C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166713 · Cited by 157
Infection of human papillomaviruses in cancers of different human organ sites.
Shukla, S., Bharti, A. C., Mahata, S., Hussain, S., Kumar, R., Hedau, S. T., & Das, B. C. (2009) · PubMed · Cited by 126
Bhatla, N., Lal, N., Bao, Y., Ng, T. Y., & Qiao, Y. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.047 · Cited by 116
Prospects and prejudices of human papillomavirus vaccines in India
Das, B. C., Hussain, S., Nasare, V. D., & Bharadwaj, M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.056 · Cited by 108
Sankaranarayanan, R., Bhatla, N., Gravitt, P. E., Basu, P. S., Esmy, P. O., Ashrafunnessa, K. S., Ariyaratne, Y., Shah, A., & Nene, B. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.005 · Cited by 108
Self-citationKulkarni, S. S., Kulkarni, S. S., Vastrad, P. P., Kulkarni, S. S., Markande, A., Kadakol, G. S., Hiremath, S. V., Kaliwal, S., Patil, B. R., & Gai, P. B. (2011) · PubMed · Cited by 97
Senapati, R., Nayak, B., Kar, S. K., & Dwibedi, B. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-016-2136-4 · Cited by 95
Epidemiology of HPV Related Malignancies
Scott‐Wittenborn, N., & Fakhry, C. (2021) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2021.04.001 · Cited by 95
Laikangbam, P., Sengupta, S., Bhattacharya, P., Duttagupta, C., Singh, T. D., Verma, Y., Roy, S. S., Das, R., & Mukhopadhyay, S. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.00827.x · Cited by 82
The present scenario of cervical cancer control and HPV epidemiology in India: an outline.
Senapathy, G. J., Umadevi, P., & Kannika, P. S. (2011) · PubMed · Cited by 70
(2009) · PubMed · Cited by 70
Haghshenas, M., Golini-moghaddam, T., Rafiei, A., Emadeian, O., Shykhpour, A., & Ashrafi, G. H. (2013) · Infectious Agents and Cancer · doi:10.1186/1750-9378-8-20 · Cited by 69
HPV & HPV vaccination: issues in developing countries.
Bharadwaj, M., Hussain, S., Nasare, V. D., & Das, B. C. (2009) · PubMed · Cited by 62
Molecular variants of HPV‐16 associated with cervical cancer in Indian population
Pillai, M. R., Hariharan, R., Babu, J. M., Lakshmi, S., Chiplunkar, S. V., Patkar, M., Tongaonkar, H. B., Dinshaw, K. A., Jayshree, R. S., Reddy, B., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24322 · Cited by 58
Prevalence of human papillomavirus types in cervical and oral cancers in central India
Gheit, T., Vaccarella, S., Schmitt, M., Pawlita, M., Franceschi, S., Sankaranarayanan, R., Sylla, B. S., Tommasino, M., & Gangane, N. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.11.041 · Cited by 68
Advancing Cervical Cancer Prevention in India: Implementation Science Priorities
Krishnan, S., Madsen, E., Porterfield, D. S., & Varghese, B. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0292 · Cited by 60
Human Papillomavirus-Type Distribution in Women With and Without Cervical Neoplasia in North India
Bhatla, N., Dar, L., Rajkumar Patro, A., Kumar, P., Pati, S. K., Kriplani, A., Gulati, A., Broor, S., Iyer, V. K., Mathur, S., et al. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31816085ba · Cited by 54
Self-citationHPV Genotyping and Site of Viral Integration in Cervical Cancers in Indian Women
Das, P. K., Thomas, A., Mahantshetty, U. M., Shrivastava, S. K., Deodhar, K., & Mulherkar, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041012 · Cited by 52
Gupta, A., Arora, R., Gupta, S. K., Prusty, B. K., Kailash, U., Batra, S., & Das, B. C. (2006) · Journal of Clinical Virology · doi:10.1016/j.jcv.2006.07.007 · Cited by 51
Promoter Hypermethylation of Tumor Suppressor Genes in Urine from Patients with Cervical Neoplasia
Feng, Q., Hawes, S. E., Stern, J., Dem, A., Sow, P. S., Dembélé, B., Touré, P. S., Sova, P., Laird, P. W., & Kiviat, N. B. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0694 · Cited by 50
DNA Methylation Profile at the DNMT3L Promoter: A Potential Biomarker for Cervical Cancer
Gokul, G., Gautami, B., Malathi, S., Sowjanya, A. P., Poli, U. R., Jain, M., Ramakrishna, G., & Khosla, S. (2007) · Epigenetics · doi:10.4161/epi.2.2.3692 · Cited by 47
Self-citationHuman papillomavirus: current status and issues of vaccination
Malik, H. I., Khan, F. H., & Ahsan, H. (2013) · Archives of Virology · doi:10.1007/s00705-013-1827-z · Cited by 44
Mattheij, I., Pollock, A. M., & Brhlíková, P. (2012) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2012.110343 · Cited by 40
Oncogenic HPV among HIV infected female population in West Bengal, India
Sarkar, K., Pal, R., Bal, B., Saha, B., Bhattacharya, S., Sengupta, S., Mazumdar, P. P., & Chakraborti, S. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-72 · Cited by 39
Salaria, D., Rolta, R., Mehta, J., Awofisayo, O., Fadare, O. A., Kaur, B., Kumar, B., da Costa, R. A., Chandel, S. R., Kaushik, N., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265420 · Cited by 39
Prevalence of human papillomavirus infection among young women in North India
Datta, P., Bhatla, N., Dar, L., Patro, A. R. K., Gulati, A., Kriplani, A., & Singh, N. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2009.12.016 · Cited by 37
Piyathilake (2010) · International Journal of Women s Health · doi:10.2147/ijwh.s6522 · Cited by 35
Neyaz, M. K., Kumar, R., Hussain, S., Naqvi, S., Kohaar, I., Thakur, N., Kashyap, V., Das, B. C., Husain, S. A., & Bharadwaj, M. (2008) · Biomarkers · doi:10.1080/13547500802078859 · Cited by 34
HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study
Odida, M., Sandin, S., Mirembe, F. M., Kleter, B., Quint, W. G. V., & Weiderpass, E. (2011) · Infectious Agents and Cancer · doi:10.1186/1750-9378-6-8 · Cited by 34
Ghosh, D. D., Bhattacharjee, B., Sen, S., Mukhopadhyay, I., & Sengupta, S. (2010) · Virology · doi:10.1016/j.virol.2010.03.030 · Cited by 33
(2014) · Europe PMC (PubMed Central) · Cited by 32
Madhivanan, P., Nishimura, H., Ravi, K., Pope, B., Coudray, M., Arun, A., Krupp, K., Jayakrishna, P., & Srinivas, V. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.3.971 · Cited by 31
Mir, B. A., Ahmad, A., Farooq, N., Priya, M. V., Siddiqui, A. H., Asif, M., Manzoor, R., Ishqi, H. M., Alomar, S. Y., & Rahaman, P. F. (2023) · Scientific Reports · doi:10.1038/s41598-023-42022-3 · Cited by 31
Worldwide Impact of the Human Papillomavirus Vaccine
Hakim, A. A., & Dinh, T. A. (2009) · Current Treatment Options in Oncology · doi:10.1007/s11864-009-0094-4 · Cited by 31
Jacob, M., Mawar, N., Menezes, L., Kaipilyawar, S., Gandhi, S., Khan, I., Patki, M., Bingham, A., LaMontagne, D. S., Bagul, R., et al. (2010) · The Open Vaccine Journal · doi:10.2174/1875035401003010096 · Cited by 29
High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women
Watt, A., Garwood, D., Jackson, M. D., Younger, N. O. M., Ragin, C. C. R., Smikle, M., Fletcher, H. M., & McFarlane‐Anderson, N. (2009) · Infectious Agents and Cancer · doi:10.1186/1750-9378-4-s1-s11 · Cited by 27
Mijit, F., Ablimit, T., Abduxkur, G., & Abliz, G. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24240 · Cited by 25
Ghosh, D. D., Bhattacharjee, B., Sen, S., Premi, L., Mukhopadhyay, I., Chowdhury, R. R., Roy, S. S., & Sengupta, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044678 · Cited by 25
Ming, P., Cai, T., Li, J., Ning, Y., Xie, S., Tao, T., & Tang, F. (2016) · Oncotarget · doi:10.18632/oncotarget.9731 · Cited by 25
Prevalence and Genotypes of HPV in Female Renal Transplant Recipients in North India
Aggarwal, R., Suri, V., Awasthi, S., Naru, J., Nijhawan, R., Minz, M., & Jha, V. (2014) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3182a54ada · Cited by 26
Human papillomavirus genotyping using HPV DNA chip analysis in Korean women
Lee, H. S., Kim, K. M., Kim, S. M., Choi, Y. D., Nam, J., Park, C. S., & Choi, H. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.00871.x · Cited by 24
Nirmala, J. G., & Narendhirakannan, R. T. (2011) · PubMed · Cited by 24
Pandey, N. O., Chauhan, A. V., Raithatha, N. S., Patel, P. K., Khandelwal, R., Desai, A. N., Choxi, Y., Kapadia, R. S., & Jain, N. D. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105149 · Cited by 23
Vinodhini, K., Shanmughapriya, S., Sanmugham, S., Senthikumar, G., Das, B. C., & Natarajaseenivasan, K. (2012) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2012.06.019 · Cited by 23
Bhattacharjee, B., Mondal, N. R., Roy, S. S., & Sengupta, S. (2008) · Virology · doi:10.1016/j.virol.2008.04.007 · Cited by 23
Status and Determinants of Early Detection of Oral Premalignant and Malignant Lesions in India
Shruti, T., Khanna, D., Khan, A., Dandpat, A., Tiwari, M., Singh, A. G., Mishra, A., Shetty, A., Birur, P. N., & Chaturvedi, P. (2023) · Cancer Control · doi:10.1177/10732748231159556 · Cited by 22
Parvez, R., Vijayachari, P., Thiruvengadam, K., Roy, A., Saha, M. K., Ramasamy, J., Vins, A., Biswas, L., Vaz, A., Kaur, H., et al. (2024) · BMC Women's Health · doi:10.1186/s12905-024-02967-7 · Cited by 21
Chong, P. P., Asyikin, N., Rusinahayati, M., Halimatun, S., Rozita, R., Ng, C. K., Hamilton, W. H. W., Tan, B. C., Noraihan, N., Rohani, A., et al. (2010) · PubMed · Cited by 20
Gupta, S., Purwar, S., Gupta, P., Halder, A., Gupta, A., Pushpalatha, K., & John, J. H. (2022) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2022/3932110 · Cited by 21
Human papillomavirus and control of cervical cancer in India
Bharti, A. C., Shukla, S., Mahata, S., Hedau, S. T., & Das, B. C. (2010) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.10.23 · Cited by 19
Advancing Cervical Cancer Prevention in India: Implementation Science Priorities
Krishnan, S., Madsen, E., Porterfield, D. S., & Varghese, B. (2013) · The Oncologist · doi:10.1634/theoncologist.18-s2-13 · Cited by 20
Dobec, M., Bannwart, F., Kaeppeli, F., & Cassinotti, P. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.03.005 · Cited by 19
Kabekkodu, S. P., Bhat, S., Pandey, D., Varghese, V. K., Shukla, V., Ghosh, S., Kushtagi, P., Bhat, P. V., Gopinath, P. M., & Satyamoorthy, K. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.5.2073 · Cited by 19
Kuriakose, S., Sabeena, S., Binesh, D., Abdulmajeed, J., Ravishankar, N., Ramachandran, A., Vijaykumar, B., & Ameen, N. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13116 · Cited by 21
Das, C. R., Tiwari, D., Dongre, A., Khan, M. A., Husain, S. A., Sarma, A., Bose, S., & Bose, P. D. (2018) · Viral Immunology · doi:10.1089/vim.2017.0151 · Cited by 20
Cervical cancer and human papillomavirus in indigenous Guyanese women
Kightlinger, R. S., Irvin, W. P., Archer, K. J., Huang, N. W., Wilson, R. A., Doran, J. R., Quigley, N. B., & Pinkerton, J. V. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.03.015 · Cited by 17
Human papillomavirus genotyping by multiplex pyrosequencing in cervical cancer patients from India
Travasso, C., Anand, M., Samarth, M., Deshpande, A., & Kumar‐Sinha, C. (2008) · Journal of Biosciences · doi:10.1007/s12038-008-0023-x · Cited by 17
Human Papillomavirus Type 73 in Primary and Recurrent Periungual Squamous Cell Carcinoma
Guldbakke, K. K., Brodsky, J., Liang, M. W., & SCHANBACHER, C. F. (2008) · Dermatologic Surgery · doi:10.1097/00042728-200803000-00023 · Cited by 17
Singh, M. P., Kaur, M., Gupta, N., Kumar, A., Goyal, K., Sharma, A. G., Majumdar, M., Gupta, M., & Ratho, R. K. (2016) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.188325 · Cited by 19
Mehdi, H. K., Raju, K., & Sheela, S. (2023) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_43_21 · Cited by 16
Kumar, A., Hussain, S., Sharma, G., Mehrotra, R., Gissmann, L., Das, B. C., & Bharadwaj, M. (2015) · Scientific Reports · doi:10.1038/srep15751 · Cited by 16
Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis
Sen, S., Mandal, P., Bhattacharya, A., Kundu, S., Chowdhury, R. R., Mondal, N. R., Chatterjee, T., Chakravarty, B., Roy, S. S., & Sengupta, S. (2017) · Tumor Biology · doi:10.1177/1010428317699799 · Cited by 18
Mandal, P., Bhattacharjee, B., Ghosh, D. D., Mondal, N. R., Chowdhury, R. R., Roy, S. S., & Sengupta, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065647 · Cited by 16
Satapathy, P., Khatib, M. N., Neyazi, A., Qanawezi, L., Said, S., Gaidhane, S., Zahiruddin, Q. S., Rustagi, S., Al‐Hajeili, M., Abdulkhaliq, A. A., et al. (2024) · Medicine · doi:10.1097/md.0000000000038827 · Cited by 15
Bhattacharya, A., Sen, S., Mandal, P., Saha, S. S., Sarkar, S., Pathak, O. P., Biswas, L., Roy, J., Banerjee, R., Chowdhury, R. R., et al. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.03.005 · Cited by 16
Cai, H. B., Ding, X. H., & Chen, C. C. (2009) · Oncology · doi:10.1159/000195885 · Cited by 15
A population‐based study of the prevalence of HPV in three districts of Tamil Nadu, India
Sureshkumar, B. T., Shanmughapriya, S., Das, B. C., & Natarajaseenivasan, K. (2014) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2014.10.025 · Cited by 14
Cross-Sectional Study of HPV Self-Sampling among Indian Women—A Way Forward
Anand, K., Mishra, G. A., Pimple, S. A., Biswas, S., Kulkarni, V., & Salunke, G. V. (2022) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0042-1742642 · Cited by 13
Detection of HPV by PCR—A Novel Step in the Prevention of Cancer Cervix
Matah, M., & Sareen, S. (2012) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-012-0167-3 · Cited by 13
Hybrid Capture 2 Assay Based Evaluation of High-Risk HPV Status in Healthy Women of North-East India
Kumar, A., Das, D., Kataki, A. C., Barmon, D., Aggarwal, D., Deka, P., Shrivastava, S., Sharma, J. D., Sarma, A., Baruah, U., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.861 · Cited by 12
Ram, B. M., Dolpady, J., Kulkarni, R., Usha, R., Bhoria, U., Poli, U. R., Islam, M., Trehanpati, N., & Ramakrishna, G. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.11.010 · Cited by 12
Self-citationRajaram, S., Gupta, G., Agarwal, S., Goel, N., & Singh, K. (2006) · Indian Journal of Cancer · doi:10.4103/0019-509x.29420 · Cited by 12
Pal, A. K., Sontakke, B. R., Ambulkar, P. S., Talhar, S., Shivkumar, P. V., & Bharambe, M. S. (2019) · Journal of Cytology · doi:10.4103/joc.joc_10_18 · Cited by 13
Barek, M. A., Basher, M. A., Aziz, M. A., Hossen, M. S., Jahan, N., Afroz, N., Begum, M., Jafrin, S., Uddin, M. S., Millat, M. S., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17712 · Cited by 11
Adult vaccination in India: A rapid review of current status & implementation challenges
Bhattacharyya, A., & Shahabuddin, S. M. (2024) · The Indian Journal of Medical Research · doi:10.25259/ijmr_1521_2024 · Cited by 11
Lagier, J., Diagne, N., Fenollar, F., Tamalet, C., Sokhna, C., & Raoult, D. (2017) · Future Microbiology · doi:10.2217/fmb-2016-0179 · Cited by 12
Mishra, G. A., Pimple, S. A., Anand, K. V., Kulkarni, V. Y., Patil, A. S., & Biswas, S. K. (2025) · International Journal of Cancer · doi:10.1002/ijc.35222 · Cited by 10
P16, Ki67 and P63 staining pattern in squamous metaplasia, CIN and cervical cancer
Jacob, A. A., & Sundaram, A. (2018) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20180608 · Cited by 10
Kadian, L. K., Gulshan, G., Ahuja, P., Singhal, G., Sharma, S., Nanda, S., & Yadav, R. (2020) · PubMed Central · Cited by 10
Viral Disease of the Cornea and External Eye
Pavan‐Langston, D. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50052-7 · Cited by 10
Mrudula, S., & Kamaraj, S. (2010) · Journal of Laboratory Physicians · doi:10.4103/0974-2727.66711 · Cited by 10
Pankaj, S., Rani, J., Kumari, P., Abhilashi, K., Choudhary, V., Kumari, S., Shahi, S. K., & Jee, B. (2024) · The National Medical Journal of India · doi:10.25259/nmji_634_21 · Cited by 13
Human papillomavirus (HPV) types 16 and 18 in liquid-based cervical cytology samples
Bhar, V. S., Gupta, N., Singh, M. P., Nijhawan, R., Srinivasan, R., Suri, V., Barward, A., Sood, S., & Rajwanshi, A. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1750-7 · Cited by 9
Advancing Cervical Cancer Prevention in India : Insights from Research and Programs
Krishnan, S., Madson, E., Porterfield, D. S., & Varghese, B. (2013) · World Bank, Washington, DC eBooks · doi:10.1596/17850 · Cited by 10
Kaur, P., Aggarwal, A., Nagpal, M., Oberoi, L., & Sharma, S. (2014) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-014-0508-5 · Cited by 9
Molecular Heterogeneity of Cervical Cancer Among Different Ethnic/Racial Populations
Chandra, S., Goswami, A., & Mandal, P. (2021) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-021-01180-8 · Cited by 9
Mudhigeti, N., Hulikal, N., Venkataramana, B., & Kalawat, U. (2022) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2022.09.004 · Cited by 8
Gupta, M., Mishra, R., & Bisht, D. (2022) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2013 · Cited by 9
Viral load and high prevalence of HR-HPV52 and 58 types in black women from rural communities
Volpini, L. P. B., Dias, J. A., de Freitas, L. B., Silva, M. C. L. F., Miranda, A. E., & Spano, L. C. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06042-6 · Cited by 8
Ali, M., Sinha, R., kumar, A., Karim, S., Irfan, M., Kumar, S., Sinha, S., Kumar, A., Ghosh, A., & Singh, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-68344-4 · Cited by 7
Oommen, A. M., Ashfaq, M., Cherian, A. G., Colling, A. M., Ramírez, A. T., Saunders, T., Singarayar, P., Thomas, V., Thomas, A., Marcus, T. A., et al. (2024) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2024.100513 · Cited by 9
Thobias, A. R., Patel, K., Gokani, R. A., Parekh, C., Desai, A., Patel, J. B., & Patel, P. S. (2019) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-019-0284-3 · Cited by 7
Gokhale, P., Sonawani, A., Idicula‐Thomas, S., Kerkar, S. C., Tongaonkar, H. B., & Mania‐Pramanik, J. (2014) · Journal of Medical Virology · doi:10.1002/jmv.23924 · Cited by 7
Parvez, R., Hedau, S. T., Bhattacharya, D., Bhattacharjee, H., Muruganandam, N., Das, B. C., Saha, M., Sugunan, A. P., & Vijayachari, P. (2011) · Public Health · doi:10.1016/j.puhe.2011.09.018 · Cited by 7
Negi, S. S., Bhargava, A., Singh, P., Aggarwal, S., Hussain, N., & Das, P. (2019) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_19_162 · Cited by 7
Community level barriers for cervical cancer screening in marginalized population
Vora, K. S., Saiyed, S., Joshi, R., & Natesan, S. K. A. (2020) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20205238 · Cited by 7
Chaloob, M. K., Hussein, A. G., & Qasim, B. J. (2016) · Europe PMC (PubMed Central) · Cited by 7
Genotypes of the human papillomavirus: relevance to Indian field trials of the vaccine.
Hariharan, I., & Pillai, M. R. (2009) · PubMed · Cited by 7
Metadata
- Authors
- Sowjanya, A. P., Jain, M., Poli, U. R., Padma, S., Das, M., Shah, K. V., Rao, B., Devi, R. R., Gravitt, P. E., & Ramakrishna, G.
- Affiliations
- Centre for DNA Fingerprinting and Diagnostics (IN)
- MaxCure Hospitals (IN)
- MNJ Institute Of Oncology and Regional Cancer Centre (IN)
- Johns Hopkins University (US)
- Corresponding author
- Ramakrishna, Gayatri
- Venue
- BMC Infectious Diseases
- Published
- 2005-12
- Volume
- 5
- Issue
- 1
- Pages
- 116-116
- ISSN
- 1471-2334 (ISSN-L)
- PMC
- PMC1345691
- OpenAlex
- W2166051067
- Cited by
- 155
- References
- 30
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 11 · 2023: 6 · 2022: 9 · 2021: 16 · 2020: 7 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 10 · 2015: 8 · 2014: 8 · 2013: 9 · 2012: 5
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Infectious Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- high-risk HPV, HPV genotype distribution, cervical squamous cell carcinoma, HPV prevalence, HPV16, HPV 18, self-collected vaginal swabs, HPV testing, cervical cancer screening, Andhra Pradesh, rural women
- MeSH terms
- Adult, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Female, Genotype, Humans, India, Middle Aged, Risk Factors, Prevalence, Papillomaviridae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review